Atlas Trials

Safety and Immunogenicity of a New Formulation of Euvichol®

Clinical trial NCT02502331 · UNKNOWN

Trial details

NCT number
NCT02502331
Sponsor
International Vaccine Institute
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Cholera
Start date
2016-03-01
Primary completion
2016-06-01
Enrollment
442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.